← Every applicant

Teva Pharms FDA Approvals

6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
LIRAGLUTIDENew drugAug 27, 2025SOLUTION, SUBCUTANEOUS
MIDOSTAURINNew drugApr 29, 2024CAPSULE, ORAL
LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023TABLET, CHEWABLE, ORAL
DOXEPIN HYDROCHLORIDENew drugFeb 17, 2023CREAM, TOPICAL
CHLORPROMAZINE HYDROCHLORIDENew drugOct 25, 2021TABLET, ORAL
PYRIMETHAMINENew drugAug 13, 2021TABLET, ORAL

Related datasets